Sachin Goel, MD
Cardiovascular Disease · Houston, TXNPI 1720255698
Payments from drug & device makers
Across 446 payments — averaging $1215.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$423K
- Medtronic$63K
- Edwards Lifesciences$30K
- Bayer$13K
- Boston Scientific$4K
- Siemens Medical Solutions USA, Inc.$4K
- plus $5K from 19 others
Across 10 payments — averaging $1080.63 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$11K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 163 | $423,041 |
| Medtronic(2 entities) | 181 | $63,130 |
| Edwards Lifesciences | 24 | $30,308 |
| Bayer | 5 | $12,591 |
| Boston Scientific | 25 | $4,419 |
| Siemens Medical Solutions USA, Inc. | 5 | $3,517 |
| W. L. Gore & Associates, Inc. | 5 | $3,220 |
| Jenavalve Technology, Inc. | 3 | $573 |
| Philips North America LLC | 6 | $559 |
| Amgen | 5 | $283 |
| Heartflow, Inc. | 1 | $113 |
| AstraZeneca | 2 | $108 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $76 |
| Ipsen Biopharmaceuticals, Inc | 2 | $55 |
| Biosense Webster, Inc. | 1 | $45 |
| Inari Medical, Inc. | 1 | $44 |
| Regeneron Healthcare Solutions, Inc. | 2 | $35 |
| Teleflex LLC | 2 | $32 |
| Cook Medical LLC | 2 | $27 |
| Boehringer Ingelheim | 1 | $23 |
| Baxter Healthcare | 1 | $23 |
| Bridgebio Pharma, Inc. | 1 | $18 |
| Johnson & Johnson | 1 | $15 |
| Scpharmaceuticals Inc. | 1 | $15 |
| Tactile Systems Technology Inc | 1 | $13 |
How this compares
$542,282 in reported general payments places this provider in the 95th percentile of 1,515 cardiovascular disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Houston
- Christie BallantyneHouston$4.6M
- Syed NaqviHouston$3.6M
- James FeldmanHouston$3.1M
- Aditya SamalHouston$2.6M
- Pranav LoyalkaHouston$2.4M
- Anwar AhmadHouston$1.4M
- Reynolds DelgadoHouston$1.1M
- Richard SmallingHouston$908K
- Amin KarimHouston$853K
- Stephen LittleHouston$806K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.